Citation only
via Europe PMC
Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases.
Chen N, Chan CK, Khan FU, Makhijani P, Valentino TR, Winer S, Luk CT, Winer DA.
Ageing research reviews · 2026
Abstract
Age-associated dysbiosis, marked by shifts in the composition of gut microbiota and gut microbiota-derived metabolites (GMDMs), is increasingly implicated in driving systemic low-grade inflammation during aging. The disrupted GMDM pools, including altered levels of short-chain fatty acids (SCFAs), secondary bile acids (BAs) and tryptophan (Trp) metabolites, lead to mucosal barrier dysfunction, immunometabolic dysregulation, and modulation of innate and adaptive immune cells. In turn, this cascade of events drives tissue degeneration, chronic inflammation, and the onset of age-related diseases (ARDs). Here, we summarize the immunomodulatory role of major GMDMs and how aging may increase susceptibility to ARDs through changing GMDMs. We then explore the latest findings linking altered GMDM profiles to immune dysfunction across major gut-organ axes, including the liver, adipose tissue, muscle, and brain. Last, we highlight recent advances in harnessing GMDMs as geromedicine to improve aging parameters and discuss the potential of artificial intelligence (AI) in accelerating the bench-to-bedside translation of GMDM research. Together, this review positions GMDMs as actionable targets in a dysbiosis-driven network of immune aging, offering new possibilities for the development of healthspan(definition)-extending precision geromedicine.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.arr.2026.103036
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
N, C., CK, C., FU, K., P, M., TR, V., S, W., CT, L., & DA., W. (2026). Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases. <em>Ageing research reviews</em>. https://doi.org/10.1016/j.arr.2026.103036
Vancouver
N C, CK C, FU K, P M, TR V, S W, et al. Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases. Ageing research reviews. 2026. doi:10.1016/j.arr.2026.103036.
BibTeX
@article{chen2026Gutmic,
title = {Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases.},
author = {Chen N and Chan CK and Khan FU and Makhijani P and Valentino TR and Winer S and Luk CT and Winer DA.},
journal = {Ageing research reviews},
year = {2026},
doi = {10.1016/j.arr.2026.103036},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular biomedicine 2026
Open access · OA
Gut microbiota and aging: current understanding and future perspectives.
The Journals of Gerontology Series A 2026
Preprint · OA
Exploring Epigenetic Aging and Cognitive Change in Middle Adulthood
Preprints.org 2026
Preprint · CC-BY
Aging-Associated Failure of Inflammation Resolution in Periodontal Disease: Macrophages at the Crossroads of Chronic Inflammation and Tissue Repair
The journals of gerontology. Series A, Biological sciences and medical sciences 2026
Citation only
Exploring epigenetic aging and cognitive change in middle adulthood.
PLoS Medicine 2018
Open access · CC-BY
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Aging Cell 2003
Open access · OA